{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T20:03:32Z","timestamp":1787601812663,"version":"build-2736575974"},"reference-count":56,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["HLA"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:p>Adoptive cell therapy using virus\u2010specific T cells (VST) is a strategy for treating common opportunistic viral infections after transplantation, particularly when these infections do not resolve through antiviral drug therapy. The availability of third\u2010party healthy donors allows for the immediate use of cells for allogeneic therapy in cases where patients lack an appropriate donor. Here, we present the creation of a cell donor registry of human leukocyte antigen (HLA)\u2010typed blood donors, REDOCEL, a strategic initiative to ensure the availability of compatible cells for donation when needed. Currently, the registry consists of 597 healthy donors with a median age of 29\u2009years, 54% of whom are women. The most represented blood groups were A positive and O positive, with 36.52% and 34.51%, respectively. Also, donors were screened for cytomegalovirus (CMV) and Epstein\u2013Barr virus (EBV). Almost 65% of donors were CMV\u2010seropositive, while less than 5% were EBV\u2010seronegative. Of the CMV\u2010seropositive donors, 98% were also EBV\u2010seropositive. High\u2010resolution HLA\u2010A, \u2010B, \u2010C, \u2010DRB1 and \u2010DQB1 allele and haplotype frequencies were determined in the registry. Prevalent HLA alleles and haplotypes were well represented to ensure donor\u2010recipient HLA\u2010matching, including alleles reported to present viral immunodominant epitopes. Since the functional establishment of REDOCEL, in May 2019, 87 effective donations have been collected, and the effective availability of donors with the first call has been greater than 75%. Thus, almost 89% of patients receiving an effective donation had available at least 5\/10 HLA\u2010matched cell donors (HLA\u2010A, \u2010B, \u2010C, \u2010DRB1, and \u2010DQB1). To summarize, based on our experience, a cell donor registry from previously HLA\u2010typed blood donors is a useful tool for facilitating access to VST therapy.<\/jats:p>","DOI":"10.1111\/tan.15419","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T06:38:22Z","timestamp":1709793502000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Development and characterization of a cell donor registry for virus\u2010specific T cell manufacture in a blood bank"],"prefix":"10.1111","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3099-067X","authenticated-orcid":false,"given":"Francesc","family":"Rudilla","sequence":"first","affiliation":[{"name":"Transfusional Medicine Group, Vall d'Hebron Research Institute, Universitat Aut\u00f2noma of Barcelona (VHIR\u2010UAB)  Barcelona Spain"},{"name":"Immunogenetics and Histocompatibility Laboratory, Blood and Tissue Bank  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Paz","family":"Carrasco\u2010Benso","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n para el Fomento de la Investigaci\u00f3n Sanitaria y Biom\u00e9dica de la Comunitat Valenciana (Fisabio)  Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Pasamar","sequence":"additional","affiliation":[{"name":"Transfusional Medicine Group, Vall d'Hebron Research Institute, Universitat Aut\u00f2noma of Barcelona (VHIR\u2010UAB)  Barcelona Spain"},{"name":"Advanced &amp; Cell Therapy Services, Blood and Tissue Bank  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"L\u00f3pez\u2010Monta\u00f1\u00e9s","sequence":"additional","affiliation":[{"name":"Transfusional Medicine Group, Vall d'Hebron Research Institute, Universitat Aut\u00f2noma of Barcelona (VHIR\u2010UAB)  Barcelona Spain"},{"name":"Advanced &amp; Cell Therapy Services, Blood and Tissue Bank  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Andr\u00e9s\u2010Rozas","sequence":"additional","affiliation":[{"name":"Transfusional Medicine Group, Vall d'Hebron Research Institute, Universitat Aut\u00f2noma of Barcelona (VHIR\u2010UAB)  Barcelona Spain"},{"name":"Advanced &amp; Cell Therapy Services, Blood and Tissue Bank  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tom\u00e1s\u2010Mar\u00edn","sequence":"additional","affiliation":[{"name":"Transfusional Medicine Group, Vall d'Hebron Research Institute, Universitat Aut\u00f2noma of Barcelona (VHIR\u2010UAB)  Barcelona Spain"},{"name":"Advanced &amp; Cell Therapy Services, Blood and Tissue Bank  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desir\u00e9e","family":"Company","sequence":"additional","affiliation":[{"name":"Fundaci\u00f3n para el Fomento de la Investigaci\u00f3n Sanitaria y Biom\u00e9dica de la Comunitat Valenciana (Fisabio)  Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Moya","sequence":"additional","affiliation":[{"name":"Blood Donors Management Department, Blood and Tissue Bank  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Larrea","sequence":"additional","affiliation":[{"name":"Centro de Transfusi\u00f3n de la Comunitat Valenciana  Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Guerreiro","sequence":"additional","affiliation":[{"name":"Department of Hematology La Fe Polytechnic and University Hospital  Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pere","family":"Barba","sequence":"additional","affiliation":[{"name":"Hospital Vall d'Hebron  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3650-1547","authenticated-orcid":false,"given":"Cristina","family":"Arbona","sequence":"additional","affiliation":[{"name":"Centro de Transfusi\u00f3n de la Comunitat Valenciana  Valencia Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Querol","sequence":"additional","affiliation":[{"name":"Transfusional Medicine Group, Vall d'Hebron Research Institute, Universitat Aut\u00f2noma of Barcelona (VHIR\u2010UAB)  Barcelona Spain"},{"name":"Advanced &amp; Cell Therapy Services, Blood and Tissue Bank  Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198812223192527"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02170"},{"issue":"18","key":"e_1_2_9_4_1","first-page":"278","article-title":"Adoptive T cell therapy for the treatment of viral infections","volume":"3","author":"Arasaratnam RJ","year":"2015","journal-title":"Ann Transl Med"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells8010047"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-2415"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.03.031"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf3700"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.835762"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1706169"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1708566"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2020.09.027"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02017-5"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0051-2"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00245-9"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13528"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2023.01.027"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101086"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-486324"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.17"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.08.024"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007103"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12754"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00410"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.07.015"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-014-0336-5"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-236356"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.12475"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01591"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23531"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00888"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1102"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI121127"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.602014"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004456"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007005"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11899-019-00528-6"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2016.10.009"},{"issue":"12","key":"e_1_2_9_39_1","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41571-022-00703-4","article-title":"T cells show promise","volume":"19","author":"Sidaway P","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016200"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells11020269"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016202"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI165476"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/tan.13644"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2017.08.011"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e318234e0e5"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019001120"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001020"},{"issue":"22","key":"e_1_2_9_49_1","first-page":"5745","article-title":"Virus\u2010specific T\u2010cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipients","volume":"4","author":"Nelson AS","year":"2020","journal-title":"Blood adv"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.73.0655"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11040845"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/256923"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000000664"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.07.016"},{"key":"e_1_2_9_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajt.2023.02.004"},{"key":"e_1_2_9_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-294X.2006.03067.x"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/tan.12356"}],"container-title":["HLA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/tan.15419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T03:19:32Z","timestamp":1711509572000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/tan.15419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1111\/tan.15419"],"URL":"https:\/\/doi.org\/10.1111\/tan.15419","archive":["Portico"],"relation":{},"ISSN":["2059-2302","2059-2310"],"issn-type":[{"value":"2059-2302","type":"print"},{"value":"2059-2310","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"2023-07-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e15419"}}